The State Common Entrance Test Cell, Mumbai, has officially started the registration process for the MAH CET 2026 for ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Mumbai: With as many as 12 newly elected BMC corporators belonging to Gen Z—aged under 30—the new House is set to get a ...

The availability of a more affordable biosimilar is expected to improve access to advanced cancer treatment not just in major ...

The current state of radiotherapeutics is “the isotope wars”, according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.

BRUNSWICK, Ohio -- The snow was kind of hiding Hinckley Lake, but my great-grandson and I headed over to see if it was ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...

The Delhi HC ruling does not abolish patents or endorse blanket early entry. Instead, it stresses courts may intervene ...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he ...

Continued strong patient recruitment in neuroendocrine tumors for lead program VMT-α-NET sets the stage for submissions of robust clinical data ...